Through the generosity of our donors, the Foundation for Peripheral Neuropathy (FPN) was able to support the IMAGiNe study with a $165,000 research grant to fund new patient enrollment for anti-MAG neuropathy. $90,000 of these funds were spent in 2022, which resulted in over 150 new patients enrolling in the study. In 2023, an additional $24,750 was spent, …
Introduction to Anti-MAG Neuropathy Anti-MAG neuropathy refers to a rare auto-immune associated cause of peripheral neuropathy (PN). In this case, the person’s own immune system (specifically, the IgM monoclonal antibodies) attack nerve cells required for a healthy peripheral nervous system – resulting in a slowly progressive and debilitating condition. Patients often experience loss of mobility, …
TREATING ANTI-MAG PN – A LOOK BACK AND WHAT MAY BE COMING Read More »
The Foundation for Peripheral Neuropathy (FPN) is pleased that the IMAGiNe study protocol has been approved for publication in the Journal of the Peripheral Nervous System. The focus of this international study is a rare autoimmune cause of PN. It is identified by high levels of the IgM protein in the blood of affected patients, …
Study Protocol on IgM Anti-Mag Neuropathy Released Read More »
Through the generosity of our donors, we’re able to support the IMAGiNe study with a $150,000 research grant to fund new patient enrollment. $90,000 of these funds, spent in 2022, resulted in over 150 new patients enrolling in the study. The IMAGiNe Study The IMAGiNe study is an international research collaborative focused on patients with …
FPN Funding Contributes $90,000 to IMAGiNe Study for anti-MAG Research Read More »
Anti-MAG peripheral neuropathy (Immunoglobulin M(IgM) Anti-Myelin Associated Glycoprotein Peripheral Neuropathy) is a rare autoimmune variety of peripheral neuropathy. In this type of PN, a person’s own immune system attacks cells that are specific in maintaining a healthy peripheral nervous system. As these cells are destroyed by antibodies, they lose function and create problems in both …
Anti-MAG peripheral neuropathy (Immunoglobulin M(IgM) Anti-Myelin Associated Glycoprotein Peripheral Neuropathy) is a rare autoimmune variety of peripheral neuropathy. In this type of PN, a person’s own immune system attacks cells that are specific in maintaining a healthy peripheral nervous system. As these cells are destroyed by antibodies, they lose function and create problems in both …
Webinar: Anti-MAG Peripheral Neuropathy: An Overview with Richard Lewis, MD Read More »
[printfriendly] Anti-MAG peripheral neuropathy (Immunoglobulin M(IgM) Anti-Myelin Associated Glycoprotein Peripheral Neuropathy) is a rare autoimmune variety of peripheral neuropathy. In this type of PN, a person’s own immune system attacks cells that are specific in maintaining a healthy peripheral nervous system. As these cells are destroyed by antibodies, they lose function and create problems in …
[printfriendly] The IMAGiNe Study (Immunoglobulin M(IgM)-Anti-myelin-associated-glycoprotein (MAG) Peripheral Neuropathy Study) aims to create a standardized database and biobank to be used for the research and analysis of Anti-MAG peripheral neuropathy. The goal is to be able to identify and predict the disease progression and treatment response, drawing on the information and DNA collected from the …
In a new study from Washington University School of Medicine in St. Louis, scientists have blocked the destruction of nerve axons in mice, a step toward helping patients with various neurodegenerative disorders, including peripheral neuropathy. The findings of this report, originally reported by Julia Evangelou Strait, can be found below. Nerve axons serve as the …
Gene Therapy Blocks Peripheral Nerve Damage in Mice Read More »
The Foundation for Peripheral Neuropathy (FPN) is pleased to announce a new partnership to further research on anti-MAG IgM paraprotein-associated peripheral neuropathy. FPN will be partnering with the IMAGiNe study, a global research collaborative focusing on anti-MAG and IgM paraprotein-associated peripheral neuropathy. Thanks to a donation from the Atlantic Philanthropies Director/Employee Designated Gift Fund, FPN …
